AK

Anit Kumar

Active Director Additional Director DIN 10125450
DIN 10125450 First appointment Apr 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Anit Kumar

Data last updated:

Anit Kumar is an Additional Director at Genderma Pharmaceuticals Private Limited (since 2023). The company operates in Trading. Genderma Pharmaceuticals Private Limited reported revenue of ₹63.1 Lakh (FY 2025).

DIN 10125450
Primary Designation Additional Director
Industry Trading
First Appointment 20 Apr 2023
Oldest Company Age 6 yrs
Largest company Genderma Pharmaceuticals Private Limited · ₹63.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director20 Apr 20232020₹63.1 Lakh (FY 2025)Active

Board colleagues of Anit Kumar

Directorship timeline

Open interactive timeline →
Genderma Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anit Kumar

Anit Kumar currently holds 1 directorship: Genderma Pharmaceuticals Private Limited (Additional Director, since 20 Apr 2023, revenue ₹63.1 Lakh (FY 2025)).

Anit Kumar was first appointed on 20 Apr 2023 as Additional Director at Genderma Pharmaceuticals Private Limited.

The current boards of Anit Kumar's companies include Mithlesh Kumari Rajput (Genderma Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available